This symposium will focus on opportunities in the Netherlands to stimulate investigator-driven clinical research (IDCR).
Clinical patient-oriented research is under strain in many countries, including the Netherlands. There are a number of reasons for this. The demand for greater efficiency in healthcare systems leaves little time for investigator-driven clinical research, and the expanding burden of bureaucracy is creating growing obstacles. As a result, the research agenda for therapeutic clinical research is driven by pharmaceutical and other companies, and important clinical and scientific questions are not always being addressed. Improving efficient investigator-initiated clinical research requires both specialised competences and an advanced infrastructure.